Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival-Reference-Cited by-同舟云学术

Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

Published:2014-06-21 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Kiba Takayoshi,Ito Takuo,Nakashima Toshihisa,Okikawa Yoshiko,Kido Miki,Kimura Akiko,Kameda Keita,Miyamae Fumiaki,Tanaka Suzuko,Atsumi Misao,Sumitani Yoko,Shitakubo Yoshimi,Niimi Hiromasa

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-462.pdf

Reference34 articles.

1. Rajkumar SV: Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol. 2012, 87 (1): 78-88.

2. Kyle RA, Rajkumar SV: Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009, 23 (1): 3-9.

3. Rajkumar SV: Doublets, triplets, or quadruplets of novel agents in newly diagnosed myeloma?. Hematology Am Soc Hematol Educ Program. 2012, 2012 (1): 354-361.

4. San Miguel JF, Mateos MV, Ocio E, Garcia-Sanz R: Multiple myeloma: treatment evolution. Hematology. 2012, 17 (Suppl 1): S3-S6.

5. International Myeloma Working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003, 121 (5): 749-757.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation;Cancers;2024-03-11

2. Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems;Blood Cancer Journal;2024-02-14

3. Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study;Hematology;2024-01-11

4. The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients;Bratislava Medical Journal;2024

5. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type;Cancer Biomarkers;2023-11-18